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Abstract  
Background: Oxidative stress can reduce the quality of sleep in patients with type 2 diabetes. 
Antioxidants such as polyphenols may increase sleep quality by improving oxidative stress 
conditions. Objective: Considering the antioxidant properties of Ellagic acid (EA), this study was 
designed to evaluate the effect of EA on sleep quality in diabetic patients. Methods: In this study, 
44 diabetic patients were recruited. Patients who met the inclusion criteria that were randomly 
allocated consumed a capsule containing 180 mg of EA per day (n = 22) or placebo (n = 22) for 
8 weeks. Anthropometric factors, physical activity, food intake, and Petersburg’s Sleep Quality 
(PSQI) questionnaire were assessed at the beginning and end of the study. Kolmogorov-Smirnov 
test, paired sample t test and independent sample t test were used to analyze the data. Results: At 
the end of the study, the mean scores of PSQI and sleep subgroups in the intervention group were 
significantly lower than in the placebo group (p < 0.05). According to intragroup comparisons, 
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these changes were significant in the intervention group at the end of the study compared to the 
beginning of the study (p < 0.05) and were not significant in the placebo group (p > 0.05). 
Conclusion: According to these findings, intake of EA may help to improve the sleep quality in 
patients with type 2 diabetes. These effects may be due to the antioxidant effects of this 
polyphenol.  
 
